{"id":"floredil","rwe":[],"tags":[{"label":"floredil","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["floredil"],"offLabel":[],"synonyms":["floredil"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"floredil","explanation":"Unfortunately, the exact mechanism of FLOREDIL is not well understood, and more research is needed to determine how it produces its effects in the body. In general, small molecule drugs like FLOREDIL are designed to bind to specific proteins or receptors, altering their activity and leading to changes in cellular behavior. This can result in a range of therapeutic effects, depending on the specific target and the drug's properties.","oneSentence":"FLOREDIL works by interacting with a specific biological target to produce a therapeutic effect.","technicalDetail":"FLOREDIL's mechanism of action is not well characterized, but it is likely to involve binding to a specific protein or receptor, altering its activity through allosteric modulation or competitive inhibition."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3748","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLOREDIL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:29:08.190816","biosimilars":[],"competitors":[],"genericName":"floredil","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"LHX2B2R19F","INN_ID":"3247","UMLSCUI":"C1880792","ChEMBL_ID":"CHEMBL2106361","PUBCHEM_CID":"216221"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"FLOREDIL","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FLOREDIL is a small molecule drug in the floredil class, but specific details about its development, ownership, and commercial status are not available. Its target and mechanism of action are also unknown. FLOREDIL is not FDA-approved, and its approved indications, half-life, bioavailability, and generic manufacturers are not specified. As a result, key safety considerations and commercial status cannot be determined. Further research is needed to understand FLOREDIL's properties and potential uses.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}